TheraCare Roll-on Lidocaine Pain Relief Liquid

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
TheraCare Roll-on Lidocaine Pain Relief Liquid
Generic name
LIDOCAINE HCI
Manufacturer
Veridian Healthcare
Product type
HUMAN OTC DRUG
SPL set ID
e942d447-754d-4683-9c99-57c7e83d7ea8
SPL ID
3f1bae48-7bd7-ffdb-e063-6394a90aa465
Version
1
Effective date
2025-09-18
Source export date
2026-10-27
Source partition
9
Source file
https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-27/a73bb3b6a943796a18cd4bcd0917240b579be4636d00e6e39481bafbd8093f69/drug-label-0009-of-0014.json.zip
Source manifest SHA-256
6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run
20261027T193451Z
Imported at
2026-10-27 20:36:22
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product use only as directed. Read and follow all directions and warnings on this carton. do not allow contact with the eyes and mucus membranes do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use do not use at the same time as other topical analgesics Stop use and ask a doctor if condition worsens redness is present irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days Flammable ■ Keep away from fire or flame If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.